Advertisement

Reactions Weekly

, Volume 1709, Issue 1, pp 223–223 | Cite as

Rituximab

Hepatitis B virus reactivation: case report
Case report
  • 11 Downloads

Reference

  1. Spinicci M, et al. Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases. European Journal of Gastroenterology and Hepatology 30: 756-760, No. 7, Jul 2018. Available from: URL: http://doi.org/10.1097/MEG.0000000000001132 - Italy

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations